简介：　　【摘 要】目的：通过测定急性冠脉综合征患者不同治疗方法后血清 CXCL16含量变化，探讨急性冠脉综合征中经皮冠脉支架植入术（ PCI）与血清 CXCL16水平关联及临床应用价值。方法：选取急性冠脉综合征患者共 32例。根据治疗方法分为 PCI组 12例，保守治疗组 20例，同时设置对照人群组 15例。采用酶联免疫吸附试验检测血清中 CXCL16浓度，使用方差分析及组间两两比较法对比组间 CXCL16浓度差异。结果：保守治疗组血清 CXCL16浓度显著高于 PCI组与对照人群组（ P<0.05）， PCI组、对照组 CXCL16浓度差异无统计学意义（ P>0.05）。结论： PCI术治疗急性冠脉综合征效果明显好于保守治疗法，具有很高的临床应用价值。  　　【关键词】急性冠脉综合征 ;经皮冠脉支架植入术 ;CXCL16;相关分析  　 [Abstract] Objective: To investigate the relationship between the level of CXCL16 and the level of PCI in patients with acute coronary syndrome (ACS) and its clinical application value. Methods: 32 patients with acute coronary syndrome were selected. According to the treatment methods, 12 cases were divided into PCI group, 20 cases in conservative treatment group and 15 cases in control group. The concentration of CXCL16 in serum was detected by enzyme-linked immunosorbent assay, and the difference of CXCL16 concentration between groups was compared by variance analysis and comparison between two groups. Results: the concentration of CXCL16 in the conservative treatment group was significantly higher than that in the PCI group and the control group (P< zero point zero five ） There was no significant difference in CXCL16 concentration between PCI group and control group (P > 0.05) zero point zero five ）。 Conclusion: PCI is better than conservative treatment in the treatment of acute coronary syndrome, and has high clinical application value.